Lemonade [LMND] vs Hanover Insurance [THG] Detailed Stock Comparison
Lemonade
NYSE
Loading...
Hanover Insurance
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Lemonade wins in 4 metrics, Hanover Insurance wins in 13 metrics, with 0 ties. Hanover Insurance appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lemonade | Hanover Insurance | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -20.13 | 11.17 | Lemonade |
| Price-to-Book Ratio | 8.04 | 1.89 | Hanover Insurance |
| Debt-to-Equity Ratio | 27.26 | 24.39 | Hanover Insurance |
| PEG Ratio | 0.78 | 12.36 | Lemonade |
| EV/EBITDA | -22.49 | 8.99 | Lemonade |
| Profit Margin (TTM) | -33.96% | 8.67% | Hanover Insurance |
| Operating Margin (TTM) | -23.52% | 12.54% | Hanover Insurance |
| EBITDA Margin (TTM) | N/A | 12.54% | N/A |
| Return on Equity | -35.10% | 19.23% | Hanover Insurance |
| Return on Assets (TTM) | -6.72% | 3.00% | Hanover Insurance |
| Free Cash Flow (TTM) | $-20.80M | $796.20M | Hanover Insurance |
| Dividend Yield | N/A | 1.59% | N/A |
| 1-Year Return | 206.37% | 25.76% | Lemonade |
| Price-to-Sales Ratio (TTM) | 7.06 | 0.95 | Hanover Insurance |
| Enterprise Value | $3.98B | $6.61B | Hanover Insurance |
| EV/Revenue Ratio | 6.63 | 1.03 | Hanover Insurance |
| Revenue per Share (TTM) | $8 | $178 | Hanover Insurance |
| Earnings per Share (Diluted) | $-2.82 | $15.18 | Hanover Insurance |
| Beta (Stock Volatility) | 2.19 | 0.46 | Hanover Insurance |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lemonade vs Hanover Insurance Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lemonade | -4.25% | 4.78% | 42.25% | 77.36% | 56.54% | 57.19% |
| Hanover Insurance | 1.73% | 1.77% | 4.93% | 1.61% | 8.50% | 13.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lemonade | 206.37% | 156.04% | -1.68% | -17.59% | -17.59% | -17.59% |
| Hanover Insurance | 25.76% | 29.33% | 64.55% | 134.18% | 317.05% | 340.91% |
Performance & Financial Health Analysis: Lemonade vs Hanover Insurance
| Metric | LMND | THG |
|---|---|---|
| Market Information | ||
| Market Cap | $4.24B | $6.07B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 4,835,860 | 211,840 |
| 90 Day Avg. Volume | 2,923,557 | 262,610 |
| Last Close | $57.20 | $172.66 |
| 52 Week Range | $15.27 - $60.41 | $132.93 - $178.68 |
| % from 52W High | -5.31% | -3.37% |
| All-Time High | $188.30 (Jan 11, 2021) | $178.68 (Jun 03, 2025) |
| % from All-Time High | -69.62% | -3.37% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.35% | 0.08% |
| Quarterly Earnings Growth | 0.35% | 2.88% |
| Financial Health | ||
| Profit Margin (TTM) | -0.34% | 0.09% |
| Operating Margin (TTM) | -0.24% | 0.13% |
| Return on Equity (TTM) | -0.35% | 0.19% |
| Debt to Equity (MRQ) | 27.26 | 24.39 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.14 | $89.59 |
| Cash per Share (MRQ) | $5.40 | $6.82 |
| Operating Cash Flow (TTM) | $-11,600,000 | $857.30M |
| Levered Free Cash Flow (TTM) | $65.96M | $624.16M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.59% |
| Last 12-Month Dividend | N/A | $2.65 |
Valuation & Enterprise Metrics Analysis: Lemonade vs Hanover Insurance
| Metric | LMND | THG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -20.13 | 11.17 |
| Forward P/E | -22.86 | 12.36 |
| PEG Ratio | 0.78 | 12.36 |
| Price to Sales (TTM) | 7.06 | 0.95 |
| Price to Book (MRQ) | 8.04 | 1.89 |
| Market Capitalization | ||
| Market Capitalization | $4.24B | $6.07B |
| Enterprise Value | $3.98B | $6.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.63 | 1.03 |
| Enterprise to EBITDA | -22.49 | 8.99 |
| Risk & Other Metrics | ||
| Beta | 2.19 | 0.46 |
| Book Value per Share (MRQ) | $7.14 | $89.59 |
Financial Statements Comparison: Lemonade vs Hanover Insurance
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LMND | THG |
|---|---|---|
| Revenue/Sales | $164.10M | $1.65B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $-42.60M | $198.80M |
| Income Tax | $1.30M | $41.90M |
| Net Income (Profit) | $-43.90M | $157.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LMND | THG |
|---|---|---|
| Cash & Equivalents | $309.20M | $315.10M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $123.70M | $722.50M |
| Total Shareholders Equity | $545.50M | $3.04B |
| Retained Earnings | $-1.36B | $3.31B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LMND | THG |
|---|---|---|
| Operating Cash Flow | $-77.00M | $58.80M |
| Capital Expenditures | $-2.30M | N/A |
| Free Cash Flow | $-49.50M | $37.10M |
| Debt Repayment | $-11.50M | N/A |
| Common Stock Repurchase | N/A | $-11.00M |
Short Interest & Institutional Ownership Analysis
| Metric | LMND | THG |
|---|---|---|
| Shares Short | 17.70M | 498,696 |
| Short Ratio | 8.56 | 1.75 |
| Short % of Float | 0.32% | 0.02% |
| Average Daily Volume (10 Day) | 4,835,860 | 211,840 |
| Average Daily Volume (90 Day) | 2,923,557 | 262,610 |
| Shares Outstanding | 72.72M | 35.90M |
| Float Shares | 62.19M | 35.44M |
| % Held by Insiders | 0.18% | 0.01% |
| % Held by Institutions | 0.54% | 0.91% |
Dividend Analysis & Yield Comparison: Lemonade vs Hanover Insurance
| Metric | LMND | THG |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.65 |
| Last 12-Month Dividend Yield | N/A | 1.59% |
| 3-Year Avg Annual Dividend | N/A | $2.79 |
| 3-Year Avg Dividend Yield | N/A | 0.62% |
| 3-Year Total Dividends | N/A | $8.38 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |